{"id":9027,"date":"2024-01-09T14:16:00","date_gmt":"2024-01-09T14:16:00","guid":{"rendered":"https:\/\/dailyai.com\/?p=9027"},"modified":"2024-01-10T09:17:28","modified_gmt":"2024-01-10T09:17:28","slug":"nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo","status":"publish","type":"post","link":"https:\/\/dailyai.com\/nb\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/","title":{"rendered":"NVIDIA utvider tilbudet av modeller for legemiddelforskning gjennom BioNeMo"},"content":{"rendered":"

NVIDIA har lagt til nye generative AI-modeller i BioNeMo, en skytjeneste for opprettelse og distribusjon av AI-modeller for legemiddelforskning.<\/b><\/p>\n

BioNeMo er en generativ AI-plattform som er utviklet for \u00e5 st\u00f8tte prosessen med legemiddeloppdagelse, som AI viste seg \u00e5 v\u00e6re sv\u00e6rt godt egnet til i 2023. <\/span>Her finnes en rekke AI-modeller og skytjenester som er spesielt skreddersydd for legemiddelutvikling.<\/span><\/p>\n

Ved \u00e5 bruke kunstig intelligens til \u00e5 modellere molekyl\u00e6re komponenter kan BioNeMo gj\u00f8re det mulig for forskere \u00e5 generere nye molekyl\u00e6re strukturer som kan f\u00f8re til effektive legemidler, noe som reduserer behovet for kostbare og tidkrevende fysiske eksperimenter.\u00a0<\/span><\/p>\n

Alle disse modellene og tjenestene st\u00f8ttes selvf\u00f8lgelig av NVIDIAs klasseledende infrastruktur for AI-maskinvare.<\/span><\/p>\n

BioNeMo kommer i tillegg til det bredere NVIDIA Clara-plattformen<\/a>. NVIDIA Clara er en databehandlingsplattform som er utviklet for \u00e5 utnytte kraften i kunstig intelligens og avansert databehandling for \u00e5 l\u00f8se utfordringer i helsesektoren.\u00a0<\/span><\/p>\n

Clara-plattformen er sentral i selskapets generative AI-helsestrategi - som if\u00f8lge NVIDIA har v\u00e6rt under utvikling i mer enn et ti\u00e5r - og tilbyr verkt\u00f8y og rammeverk som er spesielt optimalisert for bruksomr\u00e5der innen medisinsk avbildning, genomisk analyse, legemiddeloppdagelse og andre helserelaterte omr\u00e5der.\u00a0<\/span><\/p>\n

Kimberly Powell, NVIDIAs VP for helsevesenet, forklarte om BioNeMo: \"Helsevesenet er i seg selv komplisert. Vi har som m\u00e5l \u00e5 gj\u00f8re det enklere for forskere som kan finjustere disse modellene p\u00e5 propriet\u00e6re data, kj\u00f8re AI-modellinferens gjennom nettlesere eller API-er i skyen og f\u00e5 tilgang til forh\u00e5ndstrenede modeller for legemiddelutvikling.\"\u00a0<\/span><\/p>\n

Et utvalg av modeller innen bioteknologi og helsetjenester<\/h2>\n

Utvalget av verkt\u00f8y i BioNeMo er imponerende, fra NVIDIAs MolMIM-modell, som er dyktig til \u00e5 generere sm\u00e5 molekyler, til Recursions Phenom-Beta, som er en ledende modell for innbygging av cellul\u00e6re mikroskopibilder.\u00a0\u00a0<\/span><\/p>\n

Recursion er den f\u00f8rste som tilbyr en AI-modell gjennom NVIDIAs BioNeMo-sky-API-er. Phenom-Beta trekker ut funksjoner fra cellemikroskopibilder, noe som gir dypere innsikt i cellefunksjoner og hvordan celler reagerer p\u00e5 legemidler eller genetiske modifikasjoner.<\/span><\/p>\n

\"NVIDIA
Phenom-Beta er best p\u00e5 bilderekonstruksjonsoppgaver, som evaluerer modellens ytelse. Kilde: NVIDIA<\/a>.<\/figcaption><\/figure>\n

If\u00f8lge NVIDIA<\/span><\/a>Recursion oppgraderer sine superdatamaskinressurser ved \u00e5 legge til over 500 NVIDIA H100 GPU-er i systemet, noe som firedobler beregningskraften. Det blir en av de kraftigste superdatamaskinene i den biofarmas\u00f8ytiske sektoren.<\/span><\/p>\n

Oppdagelse av legemidler har utviklet seg til \u00e5 bli en av generativ AIs hovedstyrker i den vitenskapelige sektoren, med modeller som hjelper til med \u00e5 oppdage <\/span>nye klasser av antibiotika<\/span><\/a>, identifisere <\/span>forbindelser som kan bremse aldring<\/span><\/a>, og <\/span>utvikling av legemidler mot kreft<\/span><\/a>.<\/span><\/p>\n

Med sin evne til \u00e5 behandle enorme datamengder og skape ny innsikt ut fra disse dataene, oppfyller generativ AI l\u00f8ftet om \u00e5 skape nye muligheter for medisinsk og bioteknologisk forskning.<\/span><\/p>\n

Dette kommer samtidig som NVIDIA lanserer nye GPU-er og ny maskinvare<\/a> for lokal AI-behandling p\u00e5 enheten.<\/p>","protected":false},"excerpt":{"rendered":"

NVIDIA har lagt til nye generative AI-modeller i BioNeMo, en skytjeneste for \u00e5 skape og distribuere AI-modeller for legemiddelforskning. BioNeMo er en generativ AI-plattform som er utviklet for \u00e5 st\u00f8tte prosessen med legemiddeloppdagelse, som AI viste seg \u00e5 v\u00e6re sv\u00e6rt godt egnet til i 2023. Plattformen er vert for en rekke AI-modeller og skytjenester som er spesielt skreddersydd for legemiddelutvikling. Ved \u00e5 bruke kunstig intelligens til \u00e5 modellere molekyl\u00e6re komponenter gj\u00f8r BioNeMo det mulig for forskere \u00e5 generere nye molekyl\u00e6re strukturer som kan f\u00f8re til effektive legemidler, noe som reduserer behovet for kostbare og tidkrevende fysiske eksperimenter. Alle disse modellene og tjenestene er selvf\u00f8lgelig st\u00f8ttet av NVIDIAs klasseledende AI<\/p>","protected":false},"author":2,"featured_media":1059,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[83],"tags":[203,260,204,101,106],"class_list":["post-9027","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-product","tag-biotech","tag-drug-discovery","tag-healthcare","tag-medtech","tag-nvidia"],"yoast_head":"\nNVIDIA expands offerings of drug discovery models through BioNeMo | DailyAI<\/title>\n<meta name=\"description\" content=\"NVIDIA added new generative AI models to BioNeMo, a cloud service for creating and deploying AI models for drug discovery.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dailyai.com\/nb\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/\" \/>\n<meta property=\"og:locale\" content=\"nb_NO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NVIDIA expands offerings of drug discovery models through BioNeMo | DailyAI\" \/>\n<meta property=\"og:description\" content=\"NVIDIA added new generative AI models to BioNeMo, a cloud service for creating and deploying AI models for drug discovery.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dailyai.com\/nb\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/\" \/>\n<meta property=\"og:site_name\" content=\"DailyAI\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-09T14:16:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-10T09:17:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sam Jeans\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DailyAIOfficial\" \/>\n<meta name=\"twitter:site\" content=\"@DailyAIOfficial\" \/>\n<meta name=\"twitter:label1\" content=\"Skrevet av\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sam Jeans\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ansl. lesetid\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/\"},\"author\":{\"name\":\"Sam Jeans\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/person\\\/711e81f945549438e8bbc579efdeb3c9\"},\"headline\":\"NVIDIA expands offerings of drug discovery models through BioNeMo\",\"datePublished\":\"2024-01-09T14:16:00+00:00\",\"dateModified\":\"2024-01-10T09:17:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/\"},\"wordCount\":442,\"publisher\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/shutterstock_1606529806.jpg\",\"keywords\":[\"Biotech\",\"Drug discovery\",\"Healthcare\",\"MedTech\",\"Nvidia\"],\"articleSection\":[\"Product\"],\"inLanguage\":\"nb-NO\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/\",\"url\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/\",\"name\":\"NVIDIA expands offerings of drug discovery models through BioNeMo | DailyAI\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/shutterstock_1606529806.jpg\",\"datePublished\":\"2024-01-09T14:16:00+00:00\",\"dateModified\":\"2024-01-10T09:17:28+00:00\",\"description\":\"NVIDIA added new generative AI models to BioNeMo, a cloud service for creating and deploying AI models for drug discovery.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#breadcrumb\"},\"inLanguage\":\"nb-NO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nb-NO\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/shutterstock_1606529806.jpg\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/shutterstock_1606529806.jpg\",\"width\":1000,\"height\":667,\"caption\":\"Nvidia AI products\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dailyai.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NVIDIA expands offerings of drug discovery models through BioNeMo\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#website\",\"url\":\"https:\\\/\\\/dailyai.com\\\/\",\"name\":\"DailyAI\",\"description\":\"Your Daily Dose of AI News\",\"publisher\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dailyai.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nb-NO\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\",\"name\":\"DailyAI\",\"url\":\"https:\\\/\\\/dailyai.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nb-NO\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Daily-Ai_TL_colour.png\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Daily-Ai_TL_colour.png\",\"width\":4501,\"height\":934,\"caption\":\"DailyAI\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/DailyAIOfficial\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/dailyaiofficial\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@DailyAIOfficial\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/person\\\/711e81f945549438e8bbc579efdeb3c9\",\"name\":\"Sam Jeans\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nb-NO\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g\",\"caption\":\"Sam Jeans\"},\"description\":\"Sam is a science and technology writer who has worked in various AI startups. When he\u2019s not writing, he can be found reading medical journals or digging through boxes of vinyl records.\",\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/in\\\/sam-jeans-6746b9142\\\/\"],\"url\":\"https:\\\/\\\/dailyai.com\\\/nb\\\/author\\\/samjeans\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NVIDIA utvider tilbudet av modeller for legemiddelforskning gjennom BioNeMo | DailyAI","description":"NVIDIA har lagt til nye generative AI-modeller i BioNeMo, en skytjeneste for opprettelse og distribusjon av AI-modeller for legemiddelforskning.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dailyai.com\/nb\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/","og_locale":"nb_NO","og_type":"article","og_title":"NVIDIA expands offerings of drug discovery models through BioNeMo | DailyAI","og_description":"NVIDIA added new generative AI models to BioNeMo, a cloud service for creating and deploying AI models for drug discovery.","og_url":"https:\/\/dailyai.com\/nb\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/","og_site_name":"DailyAI","article_published_time":"2024-01-09T14:16:00+00:00","article_modified_time":"2024-01-10T09:17:28+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg","type":"image\/jpeg"}],"author":"Sam Jeans","twitter_card":"summary_large_image","twitter_creator":"@DailyAIOfficial","twitter_site":"@DailyAIOfficial","twitter_misc":{"Skrevet av":"Sam Jeans","Ansl. lesetid":"3 minutter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#article","isPartOf":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/"},"author":{"name":"Sam Jeans","@id":"https:\/\/dailyai.com\/#\/schema\/person\/711e81f945549438e8bbc579efdeb3c9"},"headline":"NVIDIA expands offerings of drug discovery models through BioNeMo","datePublished":"2024-01-09T14:16:00+00:00","dateModified":"2024-01-10T09:17:28+00:00","mainEntityOfPage":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/"},"wordCount":442,"publisher":{"@id":"https:\/\/dailyai.com\/#organization"},"image":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#primaryimage"},"thumbnailUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg","keywords":["Biotech","Drug discovery","Healthcare","MedTech","Nvidia"],"articleSection":["Product"],"inLanguage":"nb-NO"},{"@type":"WebPage","@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/","url":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/","name":"NVIDIA utvider tilbudet av modeller for legemiddelforskning gjennom BioNeMo | DailyAI","isPartOf":{"@id":"https:\/\/dailyai.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#primaryimage"},"image":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#primaryimage"},"thumbnailUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg","datePublished":"2024-01-09T14:16:00+00:00","dateModified":"2024-01-10T09:17:28+00:00","description":"NVIDIA har lagt til nye generative AI-modeller i BioNeMo, en skytjeneste for opprettelse og distribusjon av AI-modeller for legemiddelforskning.","breadcrumb":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#breadcrumb"},"inLanguage":"nb-NO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/"]}]},{"@type":"ImageObject","inLanguage":"nb-NO","@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#primaryimage","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg","width":1000,"height":667,"caption":"Nvidia AI products"},{"@type":"BreadcrumbList","@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dailyai.com\/"},{"@type":"ListItem","position":2,"name":"NVIDIA expands offerings of drug discovery models through BioNeMo"}]},{"@type":"WebSite","@id":"https:\/\/dailyai.com\/#website","url":"https:\/\/dailyai.com\/","name":"DagligAI","description":"Din daglige dose med AI-nyheter","publisher":{"@id":"https:\/\/dailyai.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dailyai.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nb-NO"},{"@type":"Organization","@id":"https:\/\/dailyai.com\/#organization","name":"DagligAI","url":"https:\/\/dailyai.com\/","logo":{"@type":"ImageObject","inLanguage":"nb-NO","@id":"https:\/\/dailyai.com\/#\/schema\/logo\/image\/","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/06\/Daily-Ai_TL_colour.png","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/06\/Daily-Ai_TL_colour.png","width":4501,"height":934,"caption":"DailyAI"},"image":{"@id":"https:\/\/dailyai.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/DailyAIOfficial","https:\/\/www.linkedin.com\/company\/dailyaiofficial\/","https:\/\/www.youtube.com\/@DailyAIOfficial"]},{"@type":"Person","@id":"https:\/\/dailyai.com\/#\/schema\/person\/711e81f945549438e8bbc579efdeb3c9","name":"Sam Jeans","image":{"@type":"ImageObject","inLanguage":"nb-NO","@id":"https:\/\/secure.gravatar.com\/avatar\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g","caption":"Sam Jeans"},"description":"Sam er en vitenskaps- og teknologiskribent som har jobbet i ulike oppstartsbedrifter innen kunstig intelligens. N\u00e5r han ikke skriver, leser han medisinske tidsskrifter eller graver seg gjennom esker med vinylplater.","sameAs":["https:\/\/www.linkedin.com\/in\/sam-jeans-6746b9142\/"],"url":"https:\/\/dailyai.com\/nb\/author\/samjeans\/"}]}},"_links":{"self":[{"href":"https:\/\/dailyai.com\/nb\/wp-json\/wp\/v2\/posts\/9027","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailyai.com\/nb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailyai.com\/nb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailyai.com\/nb\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/dailyai.com\/nb\/wp-json\/wp\/v2\/comments?post=9027"}],"version-history":[{"count":9,"href":"https:\/\/dailyai.com\/nb\/wp-json\/wp\/v2\/posts\/9027\/revisions"}],"predecessor-version":[{"id":9063,"href":"https:\/\/dailyai.com\/nb\/wp-json\/wp\/v2\/posts\/9027\/revisions\/9063"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailyai.com\/nb\/wp-json\/wp\/v2\/media\/1059"}],"wp:attachment":[{"href":"https:\/\/dailyai.com\/nb\/wp-json\/wp\/v2\/media?parent=9027"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailyai.com\/nb\/wp-json\/wp\/v2\/categories?post=9027"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailyai.com\/nb\/wp-json\/wp\/v2\/tags?post=9027"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}